C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/0783 (2010.01) A61K 35/50 (2006.01) A61P 35/00 (2006.01) A61K 35/12 (2006.01)
Patent
CA 2756594
Provided herein are meth-ods of suppressing tumor cell proliferation, of treating individuals having cancer or a viral infection, comprising contacting the tumor cells, or administering to the individ-ual, placental perfusate, placental perfusate cells, or natural killer cells, e.g., placenta--derived intermediate natural killer cells, with an immunomodulatory compound or thalidomide.
Cette invention concerne des méthodes de suppression de la prolifération cellulaire tumorale ainsi que le traitement d'individus atteints d'un cancer ou d'une infection virale, consistant à mettre les cellules tumorales en contact avec, ou bien à administrer à l'individu, des perfusats placentaire, des cellules de perfusat placentaire ou des cellules tueuses naturelles telles que des cellules tueuses naturelles intermédiaires d'origine placentaire, avec un composé immunomodulateur ou de la thalidomide.
Hariri Robert J.
Heidaran Mohammad
Jasko Steven
Kang Lin
Pal Ajai
Anthrogenesis Corporation
Smart & Biggar
LandOfFree
Tumor suppression using human placenta-derived intermediate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor suppression using human placenta-derived intermediate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor suppression using human placenta-derived intermediate... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1571414